stock
RLAY · Relay Therapeutics, Inc.
What Relay Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live RLAY price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on RLAY.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 219,141,631 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -2999.7%
- Net
- -2763.9%
Returns
- ROE
- -32.1%
- ROA
- -29.6%
Health
- Current ratio
- 18.3x
- Debt/equity
- —
Deep value
- NCAV
- $850.63M
- NCAV per share
- $3.88
- Price/NCAV
- Locked
- NNWC
- $43.74M
- NNWC per share
- $0.20
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $350,000 | —Gross profit: unreported by this company. | -$90.82M | -$83.71M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $3.00M | —Gross profit: unreported by this company. | -$78.59M | -$73.29M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $7.00M | —Gross profit: unreported by this company. | -$60.63M | -$54.89M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $0 | —Gross profit: unreported by this company. | -$80.39M | -$74.15M | 10-Q filed 2025-11-06 |
| 2025-06-30 | $677,000 | —Gross profit: unreported by this company. | -$76.85M | -$70.38M | 10-Q filed 2026-08-06 |
| 2025-03-31 | $7.68M | —Gross profit: unreported by this company. | -$84.87M | -$77.06M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $0 | —Gross profit: unreported by this company. | -$84.98M | -$76.00M | DEF 14A filed 2026-04-28 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $0 | —Gross profit: unreported by this company. | -$96.37M | -$88.11M | 10-Q filed 2025-11-06 |
- Assets
- $967.46M
- Equity
- $890.01M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $15.36M | -$302.74M | -$276.48M | -$235.87M |
| 2024-12-31 | $10.01M | -$372.47M | -$337.71M | -$251.13M |
| 2023-12-31 | $25.55M | -$373.00M | -$341.97M | -$304.44M |
| 2022-12-31 | $1.38M | -$299.27M | -$290.51M | -$238.55M |
| 2021-12-31 | $3.03M | -$364.70M | -$363.87M | -$77.88M |
| 2020-12-31 | $82.65M | -$55.80M | -$52.41M | -$104.42M |
| 2019-12-31 | — | -$84.05M | -$75.31M | -$74.14M |
Company filings
3 offering filings in 12 months · since Thu Aug 6
events
Material agreement, Results
Material agreementResultsAug 68-KBylaws or fiscal year change, Shareholder vote results
Bylaws or fiscal year changeShareholder vote resultsJun 98-KMaterial agreement
Material agreementMay 218-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventMay 198-KResults
ResultsMay 58-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventApr 278-K
5% owners ()
Commodore Capital LP
Stake update
Perceptive Advisors LLC
Stake update
FMR LLC
Stake update
FMR LLC
Passive stake
Point72 Asset Management, L.P.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Bergstrom Donald A
President, R&D
Sale$161,814Sep 9, 4:17 PM ET
Catinazzo Thomas
Chief Financial Officer
Sale$335,560Sep 9, 4:15 PM ET
Patel Sanjiv
President and CEO, Director
Sale$912,889Sep 9, 4:12 PM ET
Rahmer Peter
See remarks
Sale$90,295Aug 28, 4:43 PM ET
SVF Pauling (Cayman) Ltd
10% owner
Sale$116,400,000Aug 28, 9:01 AM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Duquesne Family Office
Period Tue 30 Jun 2026
0.1%New
News
Stories that named RLAY, and the market events around them.
Sign in to see thisBoard
The RLAY board could not be loaded.
Retry the RLAY boardnakagai
Signals on RLAY come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the RLAY board